MedPath

Single Shot Intrathecal Analgesia in Vaginal Delivery

Not Applicable
Recruiting
Conditions
Effectiveness of Single Shot Intra-thecal Analgesia in Multiparous Women Scheduled for Normal Vaginal Delivery
Interventions
Registration Number
NCT05998551
Lead Sponsor
Ain Shams University
Brief Summary

Effectiveness of single shot intra-thecal analgesia in multiparous women scheduled for normal vaginal delivery

Detailed Description

Labor is a physiological and natural process, as well as a complicated and subjective experience.Except for a few women, childbirth is unquestionably a painful experience. Women's understanding of delivery's pain is influenced by various factors, making each experience special. As opposed to other painful life events, labor pain consistently ranks high on the pain rating scale.

In this study ,the investigators are going to investigate the effectiveness and safety of intrathecal analgesia for labour using bupivacaine with fentanyl or dexmedetomidine.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
75
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupBupivacaine Hcl 0.5% Injparticipants will receive intrathecal injection of 5mg (1ml) of 0.5% hyperbaric bupivacaine + 1 ml normal saline
Dexmedetomidine GroupDexmedetomidineparticipants will receive intrathecal injection of 5mg (1ml) of 0.5% hyperbaric bupivacaine + 1 ml contain 5μg dexmedetomidine(0.05ml dexmedetomidine in insulin syringe+ 0.95ml normal saline).
Fentanyl groupFentanylparticipants will receive intrathecal injection of 5 mg (1ml) of 0.5% hyperbaric bupivacaine + 1 ml contain 12.5μg fentanyl(0.25ml fentanyl in insulin syringe+ 0.75ml normal saline).
Primary Outcome Measures
NameTimeMethod
Duration of pain reliefUp to 6 hours after intrathecal injection

The duration of pain relief will be defined as the duration from intrathecal injection till the VAS became more than 4

visual analogue scale (VAS) of the labour pain6 hours after intrathecal injection

The VAS (ranging from 0 = pain-free up to 10 = worst imaginable pain) of the labour pain will be recorded before the intrathecal injection, every 5 min for the first 20 min, then every 30 min for 6 hours

S1 regression time6 hours after intrathecal injection

S1 regression time will be defined as the time from intrathecal injection to sensory regression to S1 dermatome

maximum level of sensory block15 min after the intrathecal injection

Temperature will be assessed using methylated soaked swabs on both sides of the body

analgesic onset timewithin 15 minutes after intrathecal injection

The analgesia onset time will be defined as the time from intrathecal injection until the VAS became less than 4

Secondary Outcome Measures
NameTimeMethod
Maternal heart rate6 hours post operative

any change more than 20% of baseline heart rate

Maternal blood pressure6 hours post operative

any change more than 20% of baseline mean arterial pressure

Fetal APGAR scoretill 5 minutes after delivery

APGAR score (1) color, 2) heart rate, 3) reflexes, 4) muscle tone, and 5) respiration, each of which is given a score of 0, 1, or 2 at 1 and 5 minutes after delivery

Post operative nausea and vomiting6 hours post operative

Number of participants having post operative nausea and vomiting

Post operative urinary retention6 hours post operative

Number of participants having post operative urinary retention

Fetal heart soundsfrom intrathecal injection till delivery

Change more than 20% of fetal heart sounds before delivery

Trial Locations

Locations (1)

Ainshams University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath